目的对重组人生长激素-Fc(recombinant human growth hormone-Fc,rhGH-Fc)融合蛋白中试工艺的病毒灭活/去除效果进行验证,以期保证制品质量及患者安全。方法选择伪狂犬病病毒(pseudorabies virus,PRV)、异嗜性小鼠白血病病毒(xenotropic...目的对重组人生长激素-Fc(recombinant human growth hormone-Fc,rhGH-Fc)融合蛋白中试工艺的病毒灭活/去除效果进行验证,以期保证制品质量及患者安全。方法选择伪狂犬病病毒(pseudorabies virus,PRV)、异嗜性小鼠白血病病毒(xenotropic murine leukemia virus,X-MuLV)、小鼠微小病毒(minute virus of mice,MVM)、呼肠孤病毒Ⅲ型(reovirus-3,Reo-3)4种病毒作为指示病毒,在缩小规模的条件下考察有机溶剂/表面活性剂(solvent and detergent,S/D)法对PRV、X-MuLV的灭活能力;亲和层析法对X-MuLV、MVM的去除能力;膜过滤法对MVM、Reo-3的去除能力。结果S/D法对PRV和X-MuLV的灭活能力分别≥4.95、>5.15 Log;亲和层析法对X-MuLV和MVM的去除能力分别≥4.36、1.68 Log;膜过滤法对MVM和Reo-3的去除能力分别>5.36、5.40 Log。结论建立的rhGH-Fc融合蛋白灭活/去除工艺可有效灭活/去除未知的、新出现的病毒。展开更多
Background: Since it was theorised by Abdel Omran in 1971, the epidemiological transition has been well documented in Latin America, Asia and even increasingly in Africa south of the Sahara. According to this theory, ...Background: Since it was theorised by Abdel Omran in 1971, the epidemiological transition has been well documented in Latin America, Asia and even increasingly in Africa south of the Sahara. According to this theory, sub-Saharan Africa is in the first phase of development corresponding to the “age of plague and famine”. Given the health statistics currently available, more and more low- and middle-income countries, including those in sub-Saharan Africa, are experiencing an increase in mortality and the economic impact associated with non-communicable diseases. Côte d’Ivoire is one of the countries in sub-Saharan Africa where non-communicable diseases are currently on the rise. Despite the significant changes observed over the last decades, few studies have been carried out on the epidemiological transition in Côte d’Ivoire. It therefore seemed necessary to examine the changes in patterns of disease occurrence and causes of death in Côte d’Ivoire. Objectives: This work aimed to determine the reality of the epidemiological transition in Côte d’Ivoire and characterize its facies from 1990 to 2020. Methods: A literature review was carried out using PubMed, Medline, Google Scholar, Google, institutional websites (WHO, World Bank), university library websites and institutional reports from Côte d’Ivoire. The indicators sought were mortality, morbidity, life expectancy and fertility. Results: Mortality fell overall from 13.88‰ to 9.70‰, with variations linked to cyclical situations. Life expectancy rose by 52.6 to 59.03 years, although it is still below 60. Fertility has fallen from 6.3 to 4.5 children. There is a general downward trend in morbidity due to communicable diseases between 2009 and 2019, followed by an increase in non-communicable diseases. Conclusion: Côte d’Ivoire is undergoing an original and complex epidemiological transition that needs to be taken into account in health policies and strategies.展开更多
文摘Background: Since it was theorised by Abdel Omran in 1971, the epidemiological transition has been well documented in Latin America, Asia and even increasingly in Africa south of the Sahara. According to this theory, sub-Saharan Africa is in the first phase of development corresponding to the “age of plague and famine”. Given the health statistics currently available, more and more low- and middle-income countries, including those in sub-Saharan Africa, are experiencing an increase in mortality and the economic impact associated with non-communicable diseases. Côte d’Ivoire is one of the countries in sub-Saharan Africa where non-communicable diseases are currently on the rise. Despite the significant changes observed over the last decades, few studies have been carried out on the epidemiological transition in Côte d’Ivoire. It therefore seemed necessary to examine the changes in patterns of disease occurrence and causes of death in Côte d’Ivoire. Objectives: This work aimed to determine the reality of the epidemiological transition in Côte d’Ivoire and characterize its facies from 1990 to 2020. Methods: A literature review was carried out using PubMed, Medline, Google Scholar, Google, institutional websites (WHO, World Bank), university library websites and institutional reports from Côte d’Ivoire. The indicators sought were mortality, morbidity, life expectancy and fertility. Results: Mortality fell overall from 13.88‰ to 9.70‰, with variations linked to cyclical situations. Life expectancy rose by 52.6 to 59.03 years, although it is still below 60. Fertility has fallen from 6.3 to 4.5 children. There is a general downward trend in morbidity due to communicable diseases between 2009 and 2019, followed by an increase in non-communicable diseases. Conclusion: Côte d’Ivoire is undergoing an original and complex epidemiological transition that needs to be taken into account in health policies and strategies.
